SCHEMBL15525568

SCHEMBL15525568

O=C(C=Cc1ccccc1)c1nccs1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.58
KDM4E B2RXH2 2/20 0.58
NPC1 O15118 2/20 0.58
TP53 P04637 2/20 0.58
RAB9A P51151 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
MAPT P10636 7/20 0.55
LMNA P02545 3/20 0.55
MEN1 O00255 2/20 0.55
PKM P14618 1/20 0.55
MAPK1 P28482 1/20 0.55
CYP1B1 Q16678 7/20 0.51
PLIN1 O60240 2/20 0.51
RECQL P46063 2/20 0.51
PLIN5 Q00G26 2/20 0.51
ABHD5 Q8WTS1 2/20 0.51
BCHE P06276 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15525567 1.00 KMT2A (0.58) KMT2AKDM4ENPC1TP53RAB9A
SCHEMBL16685883 0.86 XDH (0.48) KMT2AKDM4ENPC1TP53RAB9A
SCHEMBL18983184 0.86 XDH (0.48) KMT2AKDM4ENPC1TP53RAB9A
SCHEMBL18983206 0.84 P4HB (0.56) KMT2AKDM4ENPC1TP53RAB9A
SCHEMBL16685923 0.84 P4HB (0.56) KMT2AKDM4ENPC1TP53RAB9A
SCHEMBL18165781 0.84 NPC1 (0.44) KMT2AKDM4ENPC1TP53RAB9A
SCHEMBL20112821 0.84 MAPT (0.54) KMT2ANPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL18153585 0.81 KMT2A (0.53) KMT2AKDM4ENPC1TP53RAB9A
SCHEMBL16685494 0.81 KMT2A (0.53) KMT2AKDM4ENPC1TP53RAB9A
SCHEMBL6292983 0.80 BCHE (0.54) KMT2ANFKB1MAPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043443-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY UNIV CASE WESTERN RESERVE (US) 2024-02-08 US disclosed
US-20210032265-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-02-04 US disclosed
US-20200140453-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-05-07 US disclosed
US-10301320-B2 Compositions and methods of modulating 15-PGDH activity UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2019-05-28 US disclosed
CN-108546254-A 5- (3- phenyl acryloyls) thiazole and the preparation method and application thereof 湖南大学 2018-09-18 CN disclosed
CN-108546254-A 5- (3- phenyl acryloyls) thiazole and the preparation method and application thereof 湖南大学 2018-09-18 CN disclosed
EP-3295940-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY Case Western Reserve University (US) 2018-03-21 EP disclosed
US-9790233-B2 Compositions and methods of modulating 15-PGDH activity CASE WESTERN RESERVE UNIVERSITY (US) 2017-10-17 US disclosed
EP-2838533-B1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY UNIV CASE WESTERN RESERVE (US) 2017-10-04 EP disclosed
US-20170165241-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2017-06-15 US disclosed
US-20150072998-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2015-03-12 US disclosed
EP-2838533-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY Case Western Reserve University (US) 2015-02-25 EP disclosed
WO-2013158649-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY CASE WESTERN RESERVE UNIVERSITY (US) 2013-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170165241-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885KDM4E 3434/4885NPC1 1675/4885
US-20200140453-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885KDM4E 3434/4885NPC1 1675/4885
US-20240043443-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885KDM4E 3434/4885NPC1 1675/4885
US-20150072998-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885KDM4E 3434/4885NPC1 1675/4885
US-20210032265-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885KDM4E 3434/4885NPC1 1675/4885
US-10301320-B2 Compositions and methods of modulating 15-PGDH activity PTGS1, HPGD, PTGIS KMT2A 4177/4885KDM4E 3434/4885NPC1 1675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.